Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid withdrawal versus steroid-based tacrolimus/MMF therapy after pediatric kidney transplantation
2005-001348-22Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2005
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tacrolimus, mycophenolate mofetil, daclizumab, prednisone and methylprednisolone (2 arms), sponsored by Astellas Pharma. Primary endpoint: Change in height standard deviation score. Started Jun 2005; status: completed.
02
Drugs
tacrolimusmycophenolate mofetildaclizumabprednisonemethylprednisolone
Beyond the preview
Go deeper on 2005-001348-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001348-22.